{"id":"https://openalex.org/W3097096801","doi":"https://doi.org/10.1182/blood-2020-134318","title":"A Phase II Study to Investigate the Efficacy and Safety of Eltrombopag in Combination with Dexamethasone As First-Line Treatment in Adult Patients with Newly Diagnosed Primary ITP (XPAG-ITP)","display_name":"A Phase II Study to Investigate the Efficacy and Safety of Eltrombopag in Combination with Dexamethasone As First-Line Treatment in Adult Patients with Newly Diagnosed Primary ITP (XPAG-ITP)","publication_year":2020,"publication_date":"2020-11-04","ids":{"openalex":"https://openalex.org/W3097096801","doi":"https://doi.org/10.1182/blood-2020-134318","mag":"3097096801"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-134318","doi":"https://doi.org/10.1182/blood-2020-134318","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-134318","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017638217","display_name":"Axel C. Matzdorff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160608","display_name":"Asklepios","ror":"https://ror.org/055tk9p53","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210160608"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Axel Matzdorff","raw_affiliation_strings":["Department of Internal Medicine II, Asklepios Clinic Uckermark, Schwedt Oder, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine II, Asklepios Clinic Uckermark, Schwedt Oder, Germany","institution_ids":["https://openalex.org/I4210160608"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077205301","display_name":"Mascha Binder","orcid":"https://orcid.org/0000-0003-0663-3004","observed_orcids":["https://orcid.org/0000-0003-0663-3004"]},"institutions":[{"id":"https://openalex.org/I4210152429","display_name":"University Hospital in Halle","ror":"https://ror.org/04fe46645","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210152429"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Mascha Binder","raw_affiliation_strings":["Department of Inner Medicine IV, Hematology and Oncology, University Hospital Halle, Halle, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Inner Medicine IV, Hematology and Oncology, University Hospital Halle, Halle, Germany","institution_ids":["https://openalex.org/I4210152429"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086501578","display_name":"Falk Nimmerjahn","orcid":"https://orcid.org/0000-0002-5418-316X","observed_orcids":["https://orcid.org/0000-0002-5418-316X"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Falk Nimmerjahn","raw_affiliation_strings":["Department of Biology, University of Erlangen-Nuremberg, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biology, University of Erlangen-Nuremberg, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058895074","display_name":"Oliver G. J. Meyer","orcid":"https://orcid.org/0000-0002-3002-333X","observed_orcids":["https://orcid.org/0000-0002-3002-333X"]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Oliver Meyer","raw_affiliation_strings":["Institute of Transfusion Medicine, Charit\u00e9 Berlin, Campus Benjamin Franklin, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Transfusion Medicine, Charit\u00e9 Berlin, Campus Benjamin Franklin, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064196229","display_name":"Mathias Rummel","orcid":"https://orcid.org/0000-0002-9278-2171","observed_orcids":["https://orcid.org/0000-0002-9278-2171"]},"institutions":[{"id":"https://openalex.org/I268975460","display_name":"Universit\u00e4tsklinikum Gie\u00dfen und Marburg","ror":"https://ror.org/032nzv584","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I268975460"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Mathias J. Rummel","raw_affiliation_strings":["Universit\u00e4tsklinikum Giessen, Giessen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e4tsklinikum Giessen, Giessen, Germany","institution_ids":["https://openalex.org/I268975460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006566224","display_name":"Tamara Tesanovic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086790","display_name":"Novartis (Germany)","ror":"https://ror.org/0013shd50","country_code":"DE","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210086790"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Tamara Tesanovic","raw_affiliation_strings":["Novartis Pharma GmbH, Nuremberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma GmbH, Nuremberg, Germany","institution_ids":["https://openalex.org/I4210086790"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022702650","display_name":"Tanja Sauer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086790","display_name":"Novartis (Germany)","ror":"https://ror.org/0013shd50","country_code":"DE","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210086790"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Tanja Sauer","raw_affiliation_strings":["Novartis Pharma GmbH, Nuremberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma GmbH, Nuremberg, Germany","institution_ids":["https://openalex.org/I4210086790"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.4999,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.66351856,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"136","issue":"Supplement 1","first_page":"36","last_page":"37"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12352","display_name":"Heparin-Induced Thrombocytopenia and Thrombosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eltrombopag","display_name":"eltrombopag","score":0.968999981880188},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9919999837875366},{"id":"https://openalex.org/keywords/primary-immune-thrombocytopenia","display_name":"primary immune thrombocytopenia","score":0.9769999980926514},{"id":"https://openalex.org/keywords/thrombopoietin-receptor-agonists","display_name":"thrombopoietin receptor agonists","score":0.9110000133514404},{"id":"https://openalex.org/keywords/newly-diagnosed-itp","display_name":"newly diagnosed ITP","score":0.8690000176429749},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7990000247955322},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6940000057220459},{"id":"https://openalex.org/keywords/platelet-count-response","display_name":"platelet count response","score":0.6980000138282776},{"id":"https://openalex.org/keywords/corticosteroid-tapering","display_name":"corticosteroid tapering","score":0.7020000219345093},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.42100000381469727},{"id":"https://openalex.org/keywords/adult-patients","display_name":"adult patients","score":0.4490000009536743},{"id":"https://openalex.org/keywords/randomized-controlled-trials","display_name":"randomized controlled trials","score":0.4000000059604645},{"id":"https://openalex.org/keywords/hemostasis","display_name":"hemostasis","score":0.34599998593330383}],"concepts":[{"id":"https://openalex.org/C2780588981","wikidata":"https://www.wikidata.org/wiki/Q411588","display_name":"Eltrombopag","level":4,"score":0.9662942290306091},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8348768949508667},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.578463077545166},{"id":"https://openalex.org/C2777863708","wikidata":"https://www.wikidata.org/wiki/Q424519","display_name":"Thrombopoietin","level":4,"score":0.5424462556838989},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.521135151386261},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5033294558525085},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3621777296066284},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.29257500171661377},{"id":"https://openalex.org/C2993327898","wikidata":"https://www.wikidata.org/wiki/Q638729","display_name":"Immune thrombocytopenia","level":3,"score":0.25491976737976074},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.15928292274475098},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2020-134318","doi":"https://doi.org/10.1182/blood-2020-134318","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-134318","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4200503264","https://openalex.org/W2077708897","https://openalex.org/W2761928918","https://openalex.org/W2253584808","https://openalex.org/W7118718339","https://openalex.org/W2909232197","https://openalex.org/W2776272713","https://openalex.org/W1994543065","https://openalex.org/W4405047777","https://openalex.org/W3161968885"],"abstract_inverted_index":{"BACKGROUND:":[0],"Eltrombopag":[1,38,193,803,840],"is":[2,58,112,121,143,179,539,606,651,804,858],"an":[3,752,805],"oral,":[4,806],"small-molecule,":[5,807],"non-peptide":[6,808],"thrombopoietin":[7,809],"receptor":[8,810],"agonist":[9,811],"(TPO-RA)":[10,812],"that":[11,813],"increases":[12,814],"hematopoiesis":[13,815],"by":[14,374,658,816],"inducing":[15,817],"proliferation":[16,818],"and":[17,44,51,126,221,227,259,303,340,464,512,519,530,819,846,851],"differentiation":[18,820],"of":[19,65,88,128,138,148,156,197,203,280,289,311,326,384,401,404,412,450,474,487,523,559,573,579,594,609,623,630,646,667,677,755,821,865],"early":[20,822],"bone":[21,823],"marrow":[22,824],"progenitor":[23,825],"cells":[24,826],"leading":[25,827],"to":[26,80,144,159,168,233,305,320,380,429,541,655,673,684,701,707,714,722,729,828,880],"increased":[27,829],"platelet":[28,93,215,324,334,440,458,503,830],"production":[29,831],"(Erickson-Miller":[30,832],"et":[31,35,116,833,837],"al.,":[32,36,117],"2010,":[33,835],"Sun":[34,836],"2012).":[37,839],"has":[39,52,841,852],"demonstrated":[40,842],"efficacy":[41,87,127,843],"in":[42,60,72,99,130,150,166,171,245,274,318,396,554,568,669,682,687,844,860,872],"adult":[43,102,544,845],"pediatric":[45,847],"patients":[46,73,104,207,491,545,688,848,873],"with":[47,74,105,152,208,276,436,546,577,591,671,689,849,874],"immune":[48],"thrombocytopenia":[49],"(ITP)":[50],"a":[53,153,161,180,277,381,410,592,853],"well-established":[54,854],"safety":[55,125,855],"profile.":[56,856],"It":[57,857],"approved":[59,859],"Europe":[61,861],"for":[62,90,299,359,390,416,480,495,566,575,601,643,862],"the":[63,146,246,257,322,348,367,397,433,439,488,521,560,607,621,628,649,665,675,863],"treatment":[64,165,223,360,434,476,481,489,499,510,574,613,634,681,864],"thrombocytopenia,":[66,866],"from":[67,363,867],"6":[68,108,868],"months":[69,869],"following":[70,247,561,870],"diagnosis,":[71,871],"primary":[75,174,211,549,604,692,875],"ITP":[76,103,133,175,212,550,850,876],"who":[77,213,332,456,582,877],"are":[78,442,563,878],"refractory":[79,879],"other":[81,388,881],"treatments":[82,882],"(e.g.":[83,883],"corticosteroids,":[84,884],"immunoglobulins).":[85,885],"The":[86,136,240,287,308,537,603],"eltrombopag":[89,149,273,312,370,668],"achieving":[91],"hemostatic":[92],"counts":[94,216,335,342,441,459,466,504],"(\u2265":[95],"50":[96,315,328],"\u00d7":[97,219,329,338,345,445,462,469,507],"109/L)":[98],"previously":[100,690],"treated":[101,427],"more":[106],"than":[107],"months'":[109],"disease":[110],"duration":[111,622],"around":[113],"80%":[114],"(Wong":[115],"2017).":[118],"However,":[119],"there":[120],"insufficient":[122],"data":[123],"on":[124,256,751],"TPO-RAs":[129],"newly":[131,172,209,547],"diagnosed":[132,173,210,548],"patients.":[134,176,392],"AIM:":[135],"aim":[137],"this":[139,569],"trial":[140,662],"(NCT04346654;":[141],"CETB115JDE01)":[142],"compare":[145],"ability":[147],"combination":[151,275,670],"short":[154,195,278],"course":[155,196,279,449],"high-dose":[157,198,204,281,405],"dexamethasone":[158,169,205,282,290,406,451,475],"induce":[160],"sustained":[162,496,610,624,631,678],"response":[163,497,625,632,679],"off":[164,498,612,626,633,680],"comparison":[167,683],"monotherapy":[170],"METHODS:":[177],"This":[178,661],"Phase":[181],"II,":[182],"multicenter,":[183],"randomized":[184,232],"(1:1),":[185],"open-label":[186],"study":[187,241,535,538,650],"(see":[188],"Figure":[189],"1).":[190],"Arm":[191,235,238,268,393],"A:":[192,269],"+":[194],"dexamethasoneArm":[199],"B:":[200,394],"1-3":[201,402,472],"cycles":[202,403,473],"Adult":[206],"have":[214,583],"<":[217],"30":[218,337,344,461,468,506],"109/L":[220,339,346,446,463,470,508],"require":[222],"will":[224,230,242,252,271,291,313,356,371,425,452,477,492,663],"be":[225,231,243,253,292,314,357,372,426,453,478,493,656],"screened,":[226],"if":[228],"eligible,":[229],"either":[234],"A":[236],"or":[237,597,757],"B.":[239],"conducted":[244],"periods:":[248],"Screening":[249],"Period:":[250,267],"Patients":[251,270,331,424,455,556],"screened":[254],"based":[255],"inclusion":[258,567],"exclusion":[260],"criteria":[261,562],"specified":[262],"below":[263],"Treatment":[264,395],"/":[265],"Tapering":[266],"receive":[272],"beginning":[283],"at":[284,409,420,551,614,635],"day":[285,389],"1.":[286],"dose":[288,310,383,411],"40":[293,413],"mg":[294,316,376,386,414],"QD":[295,317,415],"(daily;":[296],"quaque":[297],"die)":[298],"4":[300,417,421],"consecutive":[301,418],"days":[302,419],"limited":[304],"1":[306],"cycle.":[307],"starting":[309,362],"order":[319],"achieve":[321],"target":[323],"count":[325],"\u2265":[327,336,343,460,467,505,516],"109/L.":[330],"reach":[333,457],"maintain":[341,465,502],"during":[347,432],"tapering":[349,368],"phase":[350],"(week":[351],"20":[352],"-":[353],"week":[354,364,528,531],"26)":[355],"eligible":[358,479,565],"discontinuation":[361,511],"26.":[365],"During":[366],"phase,":[369],"decreased":[373],"25":[375,385,552],"every":[377,387],"2":[378],"weeks":[379,422,431,637],"minimum":[382],"all":[391],"control":[398],"arm":[399],"consists":[400],"administered":[407],"orally":[408],"intervals.":[423],"up":[428],"12":[430],"period":[435],"dexamethasone.":[437],"If":[438],">":[443],"150":[444],"no":[447,513],"further":[448],"given.":[454],"after":[471,509,534],"discontinuation.":[482],"Observation":[483],"period:":[484],"After":[485],"completion":[486],"period,":[490],"observed":[494],"defined":[500],"as:":[501],"bleeding":[514,586],"events":[515,596],"Grade":[517],"II":[518],"without":[520],"use":[522],"any":[524,558],"rescue":[525],"therapy":[526],"until":[527],"52":[529,615],"78":[532,636],"respectively,":[533],"start":[536],"designed":[540],"include":[542,620],"106":[543],"sites":[553],"Germany.":[555],"meeting":[557],"not":[564],"study:":[570],"Previous":[571],"history":[572,593],"ITPPatients":[576],"diagnosis":[578],"secondary":[580,618],"thrombocytopeniaPatients":[581],"life":[584],"threatening":[585],"complications":[587],"per":[588],"physician\u00b4s":[589],"discretionPatients":[590],"thromboembolic":[595],"known":[598],"risk":[599],"factors":[600],"thromboembolism":[602],"objective":[605],"rate":[608,629,676],"responses":[611],"weeks.":[616],"Key":[617],"objectives":[619],"treatment,":[627],"as":[638,640],"well":[639],"patient-oriented":[641],"outcomes":[642],"health-related":[644],"quality":[645],"life.":[647],"Currently,":[648],"recruiting":[652],"patients,":[653],"expected":[654],"completed":[657],"2021.":[659],"CONCLUSION:":[660],"evaluate":[664],"potential":[666],"steroids":[672,685],"increase":[674],"alone":[686],"untreated":[691],"ITP.":[693],"Disclosures":[694],"Matzdorff:":[695],"Novartis":[696],"Oncology:Consultancy,":[697],"Other:":[698,704,711,719,726,735,739,743,748,761,765,769,781],"Honoraria":[699,705,712,720,727],"paid":[700,706,713,721,728],"institution;Amgen":[702],"GmbH:Consultancy,":[703,710,718],"institution;Grifols":[708],"Deutschland":[709],"institution;Swedish":[715],"Orphan":[716],"Biovitrium":[717],"institution;UCB":[723],"Biopharma":[724],"SRL:Consultancy,":[725],"institution;Roche":[730],"Pharma":[731,784,787,791,795,798],"AG:Other:":[732],"Family":[733],"stockownership.Binder:DGHO:Honoraria,":[734],"Speaker":[736,740,744,749,762,766,770,782],"Activity;Amgen":[737],"GmbH:Honoraria,":[738,747,760,768,780],"Activity;Deutsche":[741],"Krebsgesellschaft:Honoraria,":[742],"Activity;Merck":[745],"Serono":[746],"Activity;OSHO:Membership":[750],"entity's":[753],"Board":[754],"Directors":[756],"advisory":[758],"committees;Medconcept":[759],"Activity;Tumorzentrum":[763],"Anhalt:Honoraria,":[764],"Activity;Janssen-Cilag":[767],"Activity;DFG:Research":[771],"Funding;Art":[772],"tempi:Honoraria,":[773],"Other;Sanofi-Aventis":[774],"Deutschland:Honoraria,":[775],"Other;Uniklinikum":[776],"Hamburg:Honoraria,":[777],"Other;event":[778],"lab":[779],"Activity.Nimmerjahn:Novartis":[783],"GmbH:Honoraria.Meyer:Amgen":[785],"GmbH:Honoraria;Novartis":[786],"GmbH:Honoraria;Grifols":[788],"Germany:Consultancy,":[789],"Honoraria.Rummel:Roche:Honoraria;Janssen:Honoraria;Novartis":[790],"GmbH:Honoraria;Celgene:Consultancy,":[792],"Honoraria;Amgen":[793],"GmbH:Honoraria.Tesanovic:Novartis":[794],"GmbH:Current":[796,799],"Employment.Sauer:Novartis":[797],"Employment.":[800],"OffLabel":[801],"Disclosure:":[802],"al":[834,838]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2020-11-09T00:00:00"}